The SARS-CoV-2 outbreak: What we know

Di Wu, Tiantian Wu, Qun Liu, Zhicong Yang, Di Wu, Tiantian Wu, Qun Liu, Zhicong Yang

Abstract

There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak from spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.

Keywords: Clinical features; CoVID-19; Coronavirus; Diagnosis; Epidemiology; Managements strategies; SARS-CoV-2; Treatments.

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

References

    1. Weiss S.R., Leibowitz J.L. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164.
    1. A 30-hour old infant in Wuhan diagnosed and mother-to-child infection suspected. Available at:
    1. Arabi Y.M., Alothman A., Balkhy H.H. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018;19:81.
    1. Arabi Y.M., Mandourah Y., Al-Hameed F., Sindi A.A., Mekhlafi G.A.A. Corticosteroid therapy for critically Ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2020;197:757–767.
    1. Bauch C.T., Lloyd-Smith J.O., Coffee M.P., Galvani A.P. Dynamically modeling SARS and other newly emerging respiratory illnesses past, present, and future. Epidemiology. 2005;16:791–801.
    1. Burki T. Outbreak of coronavirus disease 2019. Lancet Infect Dis. 2020;S1473-3099:30076–30081.
    1. Chaolin H., Yeming W., Xingwang L. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;(395):497–506.
    1. Cheng Z.J., Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020 Epub ahead of print.
    1. Chiu W.K., Cheung P.C., Ng K.L. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med. 2003;4:279–283.
    1. Chung M., Bernheim A., Mei X., Zhang N. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology. 2020;4 Epub ahead of print.
    1. Corman V.M., Olfert LandtKaiser M., Kaiser M. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;(25):1–8.
    1. Cui J., Li F., Shi Z. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–192.
    1. Das K.M., Lee E.Y., Jawder S.E.A., Enani M.A. Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients. AJR Am J Roentgenol. 2015;205:W267–W274.
    1. DC A., GA C., LG M. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766.
    1. Diseases T.L.I. Challenges of coronavirus disease 2019. Lancet Infect Dis. 2020;S1473-3099:30072–30074.
    1. DK M., LE Y., EM A. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. Am J Roentgenol. 2015;204:736–742.
    1. Drosten C., Günther S., Preiser W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2020;348:1967–1976.
    1. European-Centre-for-Disease-Prevention-and-Control . 2020. Daily risk assessment on COVID-19, 2 March. Available at:
    1. Fuk-Woo C.J., Shuofeng Y., Kin-Hang K. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523.
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
    1. Holshue M.L., DeBolt C., Lindquist S. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Epub ahead of print.
    1. Ji W., Wang W., Zhao X., Zai J., Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol. 2020;92:433–440.
    1. Jin Y.-H., Cai L., Cheng Z.-S. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res. 2020;7:4.
    1. Lam T.T.-Y., Shum M.H.-H., Zhu H.-C. 2020. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv preprint 2020:epub.
    1. Leung G.M., Hedley A.J., Ho L.-M., Chau P. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;(141):662–673.
    1. Li Q., Guan X., Wu P. Early transmission dynamics in Wuhan, China, of novel scoronavirus-infected pneumonia. N Engl J Med. 2020 Epub ahead of print.
    1. Li X., Wang W., Zhao X. Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol. 2020;Epub ahead of print
    1. Maimuna M., MK D. Early transmissibility assessment of a novel coronavirus in Wuhan, China (January 26, 2020) SSRN. 2020 doi: 10.2139/ssrn.3524675.
    1. Malik Y.S., Sircar S., Bhat S. Emerging novel coronavirus (2019-nCoV) - current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020 Epub ahead of print.
    1. National-Health-Commission-of-the-People’s-Republic-of-China CoVID-19 News Update, up to February 24, 2020. Available at:
    1. Nicolaou S., Al-Nakshabandi N.A., Müller N.L. SARS: imaging of severe acute respiratory syndrome. AJR Am J Roentgenol. 2003;180:1247–1249.
    1. Ooi G.C., Khong P.L., Khong P.L., Yiu W.C., Zhou L.J. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004;230:836–844.
    1. Peeri N.C., Shrestha N., Rahman M.S. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020
    1. Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382:760–762.
    1. Phelan A.L., Katz R., Gostin L. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020 Epub ahead of print.
    1. Shen K., Yang Y., Wang T. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr. 2020 Epub ahead of print.
    1. Stoecklin S.B., Rolland P., Silue Y., Mailles A. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures 2020. Euro Surveill. 2020;25
    1. Tang B., Wang X., Li Q. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020;9:1–13.
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Epub ahead of print.
    1. Wang T., Wang W., Wang Y. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020 Epub ahead of print.
    1. Weijie G., Zhengyi N., Yu H. 2020. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint.
    1. WHO How does COVID-19 spread? Available at:
    1. WHO WHO Director-General’s opening remarks at the media briefing on COVID-19-2 March 2020. Available at:
    1. WHO Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) Available at:
    1. Epidemiology Working Group for NCIP Epidemic Response CCfDCaP The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020;(41):145–151.
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020 Epub ahead of print.
    1. Yang D., Leibowitz J.L. The structure and functions of coronavirus genomic 3’ and 5’ ends. Virus Res. 2015;206:120–133.
    1. Yu F., Du L., Ojcius D.M., Pan C., Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;S1286-4579:30025–30033.
    1. Zaki A.M., Boheemen S.V., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820.
    1. Zhang S., Diao M., Yu W., Pei L., Lin Z., Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. Int J Infect Dis. 2020
    1. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Epub ahead of print.
    1. Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
    1. Zhu H., Wang L., Fang C. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9:51–60.
    1. Zumla A., Hui D.S., Azhar E.I., Memish Z.A., Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395:e35–e36.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir